ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

In Brief: Mary-Claire King Named Disney Professor By Cancer Society; Date Corrected In Article

July 1, 1994